Navigation Links
Calithera Biosciences Secures $35 Million in Series D Financing
Date:10/29/2013

SOUTH SAN FRANCISCO, Calif., Oct. 29, 2013 /PRNewswire/ -- Calithera Biosciences, a biotechnology company focused on the development of novel cancer therapeutics, today announced the successful completion of a $35 million Series D financing led by Adage Capital Partners, LP.  Joining Adage as new investors in this financing are the Longwood Fund and two other institutional investor groups.  Existing investors Morgenthaler Ventures, Advanced Technology Ventures and Delphi Ventures, who have funded the company through earlier rounds of financing, also participated in the transaction.  In conjunction with this financing, Christoph Westphal, MD, PhD, Partner and Co-Founder of the Longwood Fund, will join Calithera's Board of Directors as an observer.

Calithera will use the proceeds from the financing to accelerate the development of the company's lead clinical-stage candidate CB-839 through Phase 1 clinical trials in patients with advanced solid and hematological tumors.  CB-839 is a potent and selective orally bioavailable glutaminase inhibitor that blocks the growth and survival of many different types of cancer cells by interfering with their metabolism of glutamine.  Calithera will also continue to develop its pipeline of novel therapeutics, including an inhibitor of MCL-1, an anti-apoptotic BCL-2 homolog over-expressed in many cancers.

"With this strong support from new and current investors, we will advance CB-839 through an early set of clinical trials aimed at identifying specific populations of cancer patients with glutamine-dependent tumors that would benefit from treatment with CB-839," said Susan Molineaux, PhD, President and Chief Executive Officer of Calithera Biosciences.  "CB-839 has demonstrated promising anti-tumor activity in a broad range of tumor types that depend on glutaminase for cell growth and survival.  W
'/>"/>

SOURCE Calithera Biosciences
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Pressure BioSciences, Inc. and Target Discovery, Inc. Expand Strategic License Agreement and Collaboration Supporting TDIs Planned Offering of Personalized Medicine Clinical Diagnostic Services
2. Neurocrine Biosciences Announces Conference Call and Webcast to Present First Quarter 2012 Financial Results
3. Amarantus BioSciences to Present at the New York Biotechnology Association (NYBA) 21st Annual Meeting on May 2nd, 2012
4. Neurocrine Biosciences Reports First Quarter 2012 Results
5. Pressure BioSciences, Inc. to Discuss First Quarter 2012 Financial Results And Provide Business Update
6. Ambit Biosciences and Teva Announce Clearance of an Investigational New Drug (IND) Application for CEP-32496, A Novel BRAF(V600E) Inhibitor
7. Neurocrine Biosciences to Present at the Jefferies 2012 Global Healthcare Conference
8. 3-V Biosciences To Present at the Seventh Annual JMP Securities Healthcare Conference
9. Sofie Biosciences receives $1M Phase II SBIR grant from the DOE
10. Frost & Sullivan 2012 New Product Innovation in Bioanalytics Awarded to Protea Biosciences
11. Pressure BioSciences Patented PCT Platform Shown to Significantly Improve Protein and DNA Detection in Multiple Studies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... ADELAIDE, Australia , Aug. 31, 2015 ... the discovery and development of innovative therapeutics for the ... and cancer, today announced that its BNC101 IND submission ... Administration (FDA). Bionomics plans to initiate a Phase 1 ... in patients with metastatic pancreatic cancer prior to 31 ...
(Date:8/30/2015)... 30, 2015 La solución ... l cuidado al paciente a ... Royal Philips  (NYSE: PHG, AEX: ... IntelliSpace Cardiovascular , un sistema web de gestión de ... analizar y compartir imágenes cardiovasculares e información en cualquier ...
(Date:8/28/2015)... Calif. , Aug. 28, 2015  CytomX Therapeutics, ... treatment of cancer, today announced the filing of a ... and Exchange Commission (SEC) relating to a proposed initial ... shares to be offered and the price range for ... to list its common stock under the symbol "CTMX" ...
Breaking Medicine Technology:Successful BNC101 IND Submission Paves Way for Development of Promising Cancer Stem Cell Drug Candidate 2Successful BNC101 IND Submission Paves Way for Development of Promising Cancer Stem Cell Drug Candidate 3Successful BNC101 IND Submission Paves Way for Development of Promising Cancer Stem Cell Drug Candidate 4Philips presenta IntelliSpace Cardiovascular en el Congreso ESC 2015 2Philips presenta IntelliSpace Cardiovascular en el Congreso ESC 2015 3CytomX Files Registration Statement for Proposed Initial Public Offering 2
(Date:8/31/2015)... ... August 31, 2015 , ... Castle Dermatology Institute now ... Dr. Pedram Ghasri is a graduate of the University of California, Los Angeles. He ... studies at the University of California, Irvine Medical School. As a nationally recognized Regents ...
(Date:8/31/2015)... , ... August 31, 2015 , ... In preparation for ... Research, maker of the BEAN™ personal sound amplifier, is offering caregivers “7 Reasons to ... as a way of coping with a variety of home healthcare challenges, specifically as ...
(Date:8/31/2015)... ... August 31, 2015 , ... For 12 years, since ... acknowledged September 26th as Mesothelioma Awareness Day . On this day, and in ... several ways of becoming involved and helping the cause. , “One of the ways ...
(Date:8/31/2015)... ... August 31, 2015 , ... MeYou Health ®, a ... mobile walking app, Walkadoo , by including an in-app step tracker. , ... to each person’s walking habits. Rather than broadly assign every Walkadoo member 10,000 steps ...
(Date:8/31/2015)... ... 2015 , ... It’s a lot like coming home. Life-long Fox Valley resident ... his first days on the job, he’s run into residents of the retirement community ... knowing that they’re living in such a wonderful place,” he said. GreenFields, which is ...
Breaking Medicine News(10 mins):Health News:Castle Dermatology Institute Now Welcomes Dr. Pedram Ghasri to the Practice 2Health News:Etymotic Offers Caregivers “7 Reasons to Care about Hearing Health” 2Health News:Etymotic Offers Caregivers “7 Reasons to Care about Hearing Health” 3Health News:Cancer Research Organization Paints the World in Mesothelioma Awareness 2Health News:Cancer Research Organization Paints the World in Mesothelioma Awareness 3Health News:Walkadoo™ Walking Program Now Includes In-app Step Tracker 2Health News:Friendship Senior Options Welcomes New Executive Director for GreenFields of Geneva 2
... Benefits and Flavor of Fruit in a Zero-Calorie Fortified Water ... of Fruit2O(R), the original fruit flavored water, comes a new ... nutrients found in two servings of fruit with zero calories ... shown that 80 percent of Americans do not drink the ...
... ... Adoption of Healthcare Information Technology , ... Stamford, CT (PRWEB) June 4, 2009 -- IVANS, Inc. , ... survey that showed healthcare providers believe in the importance of reform, but are concerned ...
... Continued Market Leadership in Parenteral and Solutions/Nutritionals , ... Inc. (B. Braun) today announced that it had received ... highest year-over-year market share growth for distributed products in the ... , , (Logo: http://www.newscom.com/cgi-bin/prnh/20081022/NYW008LOGO ...
... overburdened if an outbreak were more severe , THURSDAY, June ... H1N1 swine flu outbreak that surfaced unexpectedly in April has ... , And those shortcomings could take on added urgency if ... fall, a new report found. , "It,s clear that ...
... , , HARRISBURG, Pa., June 4 Pennsylvania ... Estoydecidido.com , a resource tool to help Latino residents ... -- which translates to "I am determined" -- is ... site. , , "Latinos have become an emerging ...
... and the Alzheimer Research Forum announce the release of the ALS ... ), a web-based resource for researchers interested in amyotrophic lateral sclerosis ... The site is modeled on the Alzheimer Research Forum,s popular ... efforts to build a similar set of tools for ALS researchers. ...
Cached Medicine News:Health News:Fruit2O(R) Introduces New 'Essentials' Line 2Health News:Fruit2O(R) Introduces New 'Essentials' Line 3Health News:Providers Believe Healthcare Reform Will Increase Their Costs, According to IVANS Survey 2Health News:Providers Believe Healthcare Reform Will Increase Their Costs, According to IVANS Survey 3Health News:B. Braun Medical Wins Two GHX 2009 Best in Class Awards 2Health News:B. Braun Medical Wins Two GHX 2009 Best in Class Awards 3Health News:Report Gives U.S. Good Grades for Swine Flu Response 2Health News:Report Gives U.S. Good Grades for Swine Flu Response 3Health News:Report Gives U.S. Good Grades for Swine Flu Response 4Health News:Pennsylvania Department of Health Launches Spanish-Language Smoking Cessation Resource Web Site 2Health News:Prize4Life and the Alzheimer Research Forum Announce Launch of New Web-Portal for ALS Research 2Health News:Prize4Life and the Alzheimer Research Forum Announce Launch of New Web-Portal for ALS Research 3
... The Mini-PROTEAN 3 Dodeca cell runs ... conditions in just 35 minutes. Handcast gels ... with the new Model 485 gradient former ... of variation and improving reproducibility. Alternatively, Ready ...
... E-Gel® 96 and E-Gel® 48 gels ... bases, which combine the base and power ... device connects to the mother E-Base™ and ... simultaneous electrophoresis of two or more E-Gel® ...
... E-Page™ High-Throughput (HTP) Protein ... only integrated pre-cast gel ... high-throughput protein analysis. It ... gels, E-Base™ integrated power ...
... design allows "Four gels in one tank" electrophoresis. ... run 200 samples or more in one compact ... gels. To ensure even migration, the electrode height ... being run. Ideal for high throughput procedures, an ...
Medicine Products: